|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 1 273-285, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
AM Sasseville and Y Raymond
Institut du cancer de Montreal, Centre de recherche Louis-Charles Simard, Hopital Notre-Dame, Quebec, Canada.
Lamin A is synthesized in the cytoplasm as a precursor bearing a carboxyl-terminal CaaX box or isoprenylation signal. This precursor is post-translationally processed through multiple steps: isoprenylation with a farnesyl residue on the cysteine of the CaaX box, proteolytic removal of the last three amino acids, carboxymethylation of the cysteine residue and, finally, proteolytic removal of 15 amino acids from the carboxyl terminus. This last step gives rise to mature lamin A from which the isoprenylated terminus has been removed. Isoprenylation is a prerequisite for all other steps of processing. The subcellular location of these processing steps for lamin A is still a matter of debate. We have produced an antibody specific to the 18 amino acid carboxyl terminus of the lamin A precursor that does not recognize mature lamin A. This antibody detects intranuclear foci by immunofluorescence. Larger amounts of lamin A precursor were accumulated by treating cells with mevinolin (MVN), an inhibitor of isoprenoid synthesis. In MVN-treated cells, the lamin A precursor accumulated most strikingly in the peripheral nuclear lamina where it was assembled, while intranuclear foci were maintained. The addition of an excess of mevalonate (MVA), which restores isoprenylation activity, to MVN-treated cells led to a progressive disappearance of the lamin A precursor from the peripheral lamina. This process was completed after 4 hours of MVA treatment, after which the lamin A precursor was restricted to intranuclear foci. We conclude from these results that the non-isoprenylated lamin A precursor appears competent for assembly into the peripheral nuclear lamina, and that all the processing steps leading to mature lamin A can occur within the nuclear space.
This article has been cited by other articles:
|
|
 |
|
  T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. K. Shumaker, L. Solimando, and R. D. Goldman Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin Genes & Dev., April 1, 2008; 22(7): 832 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sagelius, Y. Rosengardten, M. Hanif, M. R. Erdos, B. Rozell, F. S. Collins, and M. Eriksson Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease J. Cell Sci., April 1, 2008; 121(7): 969 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Rusinol and M. S. Sinensky Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J. Cell Sci., August 15, 2006; 119(Pt 16): 3265 - 3272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev, July 1, 2006; 86(3): 967 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. McClintock, L. B. Gordon, and K. Djabali Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody PNAS, February 14, 2006; 103(7): 2154 - 2159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Basso, P. Kirschmeier, and W. R. Bishop Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors J. Lipid Res., January 1, 2006; 47(1): 15 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Capanni, E. Mattioli, M. Columbaro, E. Lucarelli, V. K. Parnaik, G. Novelli, M. Wehnert, V. Cenni, N. M. Maraldi, S. Squarzoni, et al. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy Hum. Mol. Genet., June 1, 2005; 14(11): 1489 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Fiordalisi, R. L. Johnson II, C. A. Weinbaum, K. Sakabe, Z. Chen, P. J. Casey, and A. D. Cox High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase Inhibitors J. Biol. Chem., October 24, 2003; 278(43): 41718 - 41727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Moir, M. Yoon, S. Khuon, and R. D. Goldman Nuclear Lamins A and B1: Different Pathways of Assembly during Nuclear Envelope Formation in Living Cells J. Cell Biol., December 4, 2000; 151(6): 1155 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Dechat, B Korbei, O. Vaughan, S Vlcek, C. Hutchison, and R Foisner Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins J. Cell Sci., January 10, 2000; 113(19): 3473 - 3484. [Abstract] [PDF]
|
|
|
|
|
|
R. M. Barton and H. J. Worman Prenylated Prelamin A Interacts with Narf, a Novel Nuclear Protein J. Biol. Chem., October 15, 1999; 274(42): 30008 - 30018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Moraleda, S. Seeholzer, V. Bichko, R. Dunbrack, J. Otto, and J. Taylor Unique Properties of the Large Antigen of Hepatitis Delta Virus J. Virol., September 1, 1999; 73(9): 7147 - 7152. [Abstract] [Full Text]
|
|
|
|
|
|
J. Broers, B. Machiels, G. van Eys, H. Kuijpers, E. Manders, R van Driel, and F. Ramaekers Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins J. Cell Sci., January 10, 1999; 112(20): 3463 - 3475. [Abstract] [PDF]
|
|
|
|
|
|
T. Mical and M. Monteiro The role of sequences unique to nuclear intermediate filaments in the targeting and assembly of human lamin B: evidence for lack of interaction of lamin B with its putative receptor J. Cell Sci., January 12, 1998; 111(23): 3471 - 3485. [Abstract] [PDF]
|
|
|
|
|
|
T. P. Spann, R. D. Moir, A. E. Goldman, R. Stick, and R. D. Goldman Disruption of Nuclear Lamin Organization Alters the Distribution of Replication Factors and Inhibits DNA Synthesis J. Cell Biol., March 24, 1997; 136(6): 1201 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ashery-Padan, A. M. Weiss, N. Feinstein, and Y. Gruenbaum Distinct Regions Specify the Targeting of Otefin to the Nucleoplasmic Side of the Nuclear Envelope J. Biol. Chem., January 24, 1997; 272(4): 2493 - 2499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pugh, P. Coates, E. Lane, Y Raymond, and R. Quinlan Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells J. Cell Sci., January 10, 1997; 110(19): 2483 - 2493. [Abstract] [PDF]
|
|
